ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Start-ups

DNA Script gets grant for longer DNA

by Melody M. Bomgardner
July 15, 2018 | APPEARED IN VOLUME 96, ISSUE 29

DNA Script, a start-up based in Paris, has won $2.7 million in grants from Bpifrance, a state-backed program for French entrepreneurs. The company uses enzymes, rather than chemical processes, to assemble synthetic DNA for use in cell therapies and gene editing. It claims that its process makes longer DNA constructs more quickly and cleanly than competing approaches do. DNA Script raised $13 million in September 2017 from investors, including the venture arms of Illumina and Merck KGaA.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment